首页> 外国专利> CHORIONIC SOMATOMAMMOTROPIN HORMONE SPLICE VARIANTS

CHORIONIC SOMATOMAMMOTROPIN HORMONE SPLICE VARIANTS

机译:绒毛膜激素激素激素变体

摘要

The invention is based on the discovery that INSP100 is a splice variant of human chorionic somatomammotropin hormone 2 (HCS-B; Q14407) and that INSP104 is a splice variant of human chorionic somatomammotropin hormone 1 (hCS-A;P01243). The invention relates to the use of these proteins and nucleic acid sequences from the encoding genes in the diagnosis, prevention, and treatment of disease. This invention relates to novel proteins, termed INSP 100 and INSP 104, herein identified as novel splice variants of human Chorionic somatomammotropin hormone 2 (hCS-B; Q 14407 ) and human Chorionic somatomammotropin hormone 1 (hCS-A; P 01243 ) respectively and to the use of these proteins and nucleic acid sequences from the encoding genes in the diagnosis, prevention and treatment of disease. The variants have an altered A-B loop and are therefore predicted to possess altered receptor binding properties. All publications, patents and patent applications cited herein are incorporated in full by reference.
机译:本发明基于以下发现:INSP100是人绒毛膜促生长素激素2(HCS-B; Q14407)的剪接变体,而INSP104是人绒毛膜促生长素激素1(hCS-A; P01243)的剪接变体。本发明涉及来自编码基因的这些蛋白质和核酸序列在疾病的诊断,预防和治疗中的用途。本发明涉及被称为INSP 100和INSP 104的新蛋白,在本文中分别被鉴定为人绒毛膜促生长素激素2(hCS-B; Q 14407)和人绒毛膜促生长素激素1(hCS-A; P 01243)的新型剪接变体,以及这些蛋白质和编码基因的核酸序列在疾病的诊断,预防和治疗中的用途。所述变体具有改变的A-B环,因此被预测具有改变的受体结合性质。本文引用的所有出版物,专利和专利申请均通过引用全文并入。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号